The PETAL consortium is a first-of-its-kind global network of more than 100 investigators and 20 research sites.
Blog
Learn more about their unique approaches to improving care for cancer patients.
If you are a fan of sci-fi like myself, believe in aliens like my boss does, or are a cat parent that likes to get in some cat-ercise, lasers are probably a big part of your life (or at least your cat’s). But besides the occasional blaster or laser pointer, you may not think thereRead more
Mass General researcher Matt Rosen, PhD, is all too familiar with the devastating effects of a late breast cancer diagnosis.
The unrestricted funding provided by the MGH Research Scholar awards is enabling creative new approaches to cancer research.
A recent study both validated time to surgery as a standardized metric for breast cancer care and identified a worrying difference in time to surgery between Black and white patients.
How Daniel Faden, MD, and his team are working on developing and applying blood based cancer diagnostic tools.
It took contributions from almost 100 people to translate promising lab findings into a first-in-human treatment for glioblastoma.
Genevieve Boland, MD, PhD, a physician-investigator in the Cancer Center at Mass General, is researching skin cancer and related diseases.
A close-up look at the Demehri Lab and how they are working to understand the immune system’s role in early cancer development.